AI assistant
CONMED Corp — Director's Dealing 2020
Jun 3, 2020
31971_dirs_2020-06-03_cc31ef26-1f59-42ef-903a-54dce51a35e7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CONMED CORP (CNMD)
CIK: 0000816956
Period of Report: 2020-06-01
Reporting Person: TRYNISKI MARK E (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2020-06-01 | Common Stock | M | 1876 | — | Acquired | 42889 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2020-06-01 | Rsus (restricted Stock Units) | $0 | M | 1876 | Disposed | 2029-06-03 | Common Stock (1876) | Direct |
| 2020-06-01 | Rsus (restricted Stock Units) | $0 | A | 1521 | Acquired | 2030-06-01 | Common Stock (1521) | Direct |
| 2020-06-01 | Options To Purchase Common Stock | $73.94 | A | 1843 | Acquired | 2030-06-01 | Common Stock (1843) | Direct |
Footnotes
F1: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2016 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F2: Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock, par value $0.01 per share of ConMed Corporation (the "Company") and will be subject to the terms and conditions of the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan, with the RSUs generally vesting 100% after a one year period.
F3: The stock options were granted under the Company's 2020 Amended and Restated Non-Employee Director Equity Compensation Plan and generally vest 100% after a one year period.